Explore key business opportunities and trends set to shape 2025, from digital media tax credits in British Columbia to real estate developments in London and the importance of registered agents for Montana LLCs. Read more...

This article summarizes recent analyst ratings for several NASDAQ-listed stocks, including Akero Therapeutics, Alumis, Amneal Pharmaceuticals, BRP Inc., Amplitude, and SoundHound AI. Read more...

Meta faces layoffs due to leaks, while investment firms adjust their stock positions. StarPlus enhances installer skills in Nigeria. Read more...

Recent analyst reports show optimism for several companies, including Apogee Therapeutics, Avadel Pharmaceuticals, and Nvidia, with potential upside for investors. Read more...

A look at recent stock movements and analyst ratings for NASDAQ-listed companies, including Microsoft, Neumora Therapeutics, and Zions Bancorporation. Read more...

Several institutional investors adjusted their portfolios in the fourth quarter, with notable moves in companies like AMC, BorgWarner, Madison Square Garden Sports, Microsoft, and JPMorgan International Growth ETF. Read more...

A roundup of recent stock market activity, including changes in short interest, earnings expectations, analyst ratings, and institutional investor holdings for several companies. Read more...

Investment firms are making moves with Microsoft (MSFT) and other tech stocks. Some are increasing their holdings, while others are trimming their positions. Read more...

Several investment firms, including Illinois Municipal Retirement Fund, New York Life, and Oppenheimer, have adjusted their holdings in companies like NV5 Global, Zillow, and Jazz Pharmaceuticals. Nebius expresses confidence in its AI potential. Read more...

New York Life Investment Management LLC adjusts its portfolio, increasing its stake in Coca-Cola Europacific while decreasing holdings in GXO Logistics and Voya Financial. Read more...

Hideaki Nishino will become the sole CEO of Sony Interactive Entertainment on April 1, 2025. Private Advisor Group LLC also increased its Sony holdings. Read more...

Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

Several investment firms have adjusted their positions in tech giants like Meta and Adobe, as well as Hain Celestial Group. This article summarizes these recent stock transactions and earnings forecasts. Read more...

Recent SEC filings reveal that investment firms are adjusting their portfolios, with New York Life Investment Management and Sunpointe LLC increasing their holdings in Check Point and Alphabet, respectively. This news highlights investor confidence in the tech sector. Read more...

Several institutional investors, including Bank of New York Mellon Corp and Illinois Municipal Retirement Fund, adjusted their holdings in various companies during the fourth quarter. New York Life Investment Management LLC and Los Angeles Capital Management LLC also made new investments. Read more...

Several institutional investors, including First Bank & Trust, Illinois Municipal Retirement Fund, and New York Life Investment Management LLC, have adjusted their stock portfolios recently. Read more...

A look at recent stock activity including New York Life's investment in WillScot, DocuSign's upcoming earnings, promising growth stocks PTC and Trimble, and SoundHound AI's potential rebound. Read more...

Apple reportedly halts AR glasses development, focusing instead on robotics for the smart home. Plus, a firmware update for AirPods Max. Read more...

A look at the latest earnings estimates and analyst outlook for several companies including Alphabet, Rocket Pharmaceuticals, Pharming Group, Structure Therapeutics, uCloudlink Group, and Longeveron. Read more...

This article summarizes recent market activity, including Whipplewood Advisors' investment in Meta, analyst rating changes for Mattel and Noodles & Company, and Wedbush's updated earnings estimates for Apellis Pharmaceuticals. Read more...